Painless Skin Patch Offers New Way to Monitor Immune Health
Published: 01 Apr 2026
Author: Precedence Research
A researcher at The Jackson Laboratory collaborated with the Massachusetts Institute of Technology (MIT), it is designed in the bandage‑like device to capture inflammatory signals within minutes and collect specialised immune cells within hours, giving clinicians access to information that is impossible to obtain in routine testing. The patch is helping researchers and clinicians study immune responses in ageing and skin autoimmunity, including vitiligo and psoriasis.
Faculty member at UConn School of Medicine and a biomedical engineer and immunologist at JAX, Sasan Jalili, said the study of important immune cells in the body requires a skin biopsy. Because many of these cells live and respond in tissues like the skin, accessing them has meant invasive procedures.
Market growth is Driven by the Innovative Skin Patch
According to Towards Healthcare, the Electronic Skin Patches market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 19.05 billion in 2026 to approximately USD 55.16 billion by 2035, representing a compound annual growth rate (CAGR) of 12.54% from 2026 to 2035. Growth is driven by rising demand for wearable health monitoring, increasing prevalence of chronic diseases, advancements in sensor technologies, expanding telehealth services, growing focus on personalized healthcare, and supportive regulatory initiatives across global healthcare systems and markets.
Leveraging a natural immune alarm system
Most tests of the cells are monitored with specific infections, vaccines, or autoimmune triggers that circulate in the blood. This patch works by harnessing resident memory T cells, immune sentinels that live in skin and tissues and rapidly respond to previously encountered foreign threats. When these cells recognise a familiar antigen, such as a fragment of a virus or an allergen, they sound the alarm, releasing signals to attract additional immune cells from the bloodstream, including the highly specialised T cells that recognise the same threat.
Expanding the immune monitoring toolbox
Immune cells that drive conditions such as allergic dermatitis, psoriasis, and vitiligo already live in the tissue, patch may be useful for such skin conditions. The patch absorbs immune cells and signaling proteins from the skin after resident memory T cells are reactivated with a small amount of antigen. It contains hundreds of microscopic needles made of an FDA-approved polymer.
A recent report by Towards Healthcare highlights that the Electronic Skin Patches Market is growing rapidly, driven by increasing demand for wearable health monitoring, chronic disease management, technological advancements, and expanding telehealth adoption globally.